FDA 21 CFR Part 11
Electronic Records; Electronic Signatures (pharmaceutical/medical devices)
Framework summaries on this platform are AI-assisted interpretations for educational and compliance planning purposes. They do not reproduce or replace the official standards. Refer to the authoritative source for the definitive text. Framework names and trademarks belong to their respective organisations.
Framework Domains (12)
Audit Trail
| Code | Title |
|---|---|
| §11.10(e) | Secure, computer-generated, time-stamped audit trails |
Closed System
| Code | Title |
|---|---|
| §11.10(b) | Generation of accurate and complete copies |
| §11.10(c) | Record protection and retrieval |
| §11.10(d) | Limiting system access to authorized individuals |
| §11.10(f) | Operational system checks |
| §11.10(g) | Authority checks |
| §11.10(h) | Device checks |
Documentation
| Code | Title |
|---|---|
| §11.10(i) | Personnel qualifications and training |
| §11.10(j) | Written policies holding individuals accountable |
| §11.10(k)(1) | Distribution and access control of system documentation |
| §11.10(k)(2) | Revision and change control of system documentation |
Electronic Signature
| Code | Title |
|---|---|
| §11.100(a) | Uniqueness of electronic signatures |
| §11.100(b) | Identity verification before assigning signature |
| §11.100(c) | FDA certification of electronic signatures |
| §11.200(a)(1)(i) | Non-biometric signatures require two distinct components |
| §11.200(a)(1)(ii) | Continuous session signings |
| §11.200(a)(2) | Non-continuous signings require all components |
| §11.200(a)(3) | Signatures only usable by genuine owners |
| §11.200(b) | Biometric signature controls |
| §11.300(a) | Uniqueness of ID code and password combinations |
| §11.300(b) | Periodic checking, recalling, or revising of ID codes and passwords |
| §11.300(c) | Loss management for tokens, cards, and devices |
| §11.300(d) | Transaction safeguards against unauthorized use and detection of attempts |
| §11.300(e) | Initial and periodic testing of devices |
| §11.50(a) | Signature manifestation content |
| §11.50(b) | Signature manifestation in human-readable form |
| §11.70 | Signature/record linking |
FDA 21 CFR Part 11: Administrative Safeguards
Organizational security management (FDA 21 CFR Part 11)
| Code | Title |
|---|---|
| FDA-CFR11-06 | Security management process and risk analysis |
| FDA-CFR11-07 | Workforce security and clearance procedures |
| FDA-CFR11-08 | Information access management |
| FDA-CFR11-09 | Security awareness and training program |
| FDA-CFR11-10 | Contingency planning for ePHI |
| FDA-CFR11-11 | Business associate management |
FDA 21 CFR Part 11: Organizational Requirements
Policies, procedures, and documentation (FDA 21 CFR Part 11)
| Code | Title |
|---|---|
| FDA-CFR11-21 | Security and privacy policies |
| FDA-CFR11-22 | Documentation and record retention |
| FDA-CFR11-23 | Compliance evaluation and review |
| FDA-CFR11-24 | Incident reporting procedures |
FDA 21 CFR Part 11: Patient Data Protection
Safeguarding protected health information (FDA 21 CFR Part 11)
| Code | Title |
|---|---|
| FDA-CFR11-01 | ePHI access controls and authorization |
| FDA-CFR11-02 | ePHI encryption at rest and in transit |
| FDA-CFR11-03 | Minimum necessary standard enforcement |
| FDA-CFR11-04 | Patient data de-identification procedures |
| FDA-CFR11-05 | Audit trail for ePHI access |
FDA 21 CFR Part 11: Physical Safeguards
Physical security for systems with ePHI (FDA 21 CFR Part 11)
| Code | Title |
|---|---|
| FDA-CFR11-17 | Facility access controls |
| FDA-CFR11-18 | Workstation security and use policies |
| FDA-CFR11-19 | Device and media controls |
| FDA-CFR11-20 | Disposal and re-use procedures |
FDA 21 CFR Part 11: Technical Safeguards
Technical measures for ePHI protection (FDA 21 CFR Part 11)
| Code | Title |
|---|---|
| FDA-CFR11-12 | Unique user identification and authentication |
| FDA-CFR11-13 | Automatic logoff and session management |
| FDA-CFR11-14 | Audit controls and monitoring |
| FDA-CFR11-15 | Integrity controls for ePHI |
| FDA-CFR11-16 | Transmission security and encryption |
Open System
| Code | Title |
|---|---|
| §11.30 | Controls for open systems |
Other
| Code | Title |
|---|---|
| §11.1(a) | Scope of Part 11 |
| §11.2(a) | Implementation for paper-equivalent records |
| §11.2(b) | Electronic submissions to FDA |
| §11.3(b) | Definitions of key terms |
Validation
| Code | Title |
|---|---|
| §11.10(a) | Validation of closed systems |
Your Compliance Coverage
If you comply with FDA 21 CFR Part 11, you already cover:
NIS2 Directive Implementing Acts
19%
11 controls mapped
Compare →ISO 13485
19%
11 controls mapped
Compare →UK Telecommunications (Security) Act 2021
19%
11 controls mapped
Compare →+ 564 more: US Gramm-Leach-Bliley Act (GLBA) - Higher Education Safeguards Rule (19%), NIST SP 800-66 (19%)
See all 567 mapped frameworks ↓Maps to 567 other frameworks
Frequently Asked Questions
What is FDA 21 CFR Part 11?
FDA 21 CFR Part 11 is a compliance framework from United States with 12 domains and 57 controls. Electronic Records; Electronic Signatures (pharmaceutical/medical devices) It is used by organisations to establish and maintain compliance with industry standards and regulatory requirements.
How many controls does FDA 21 CFR Part 11 have?
FDA 21 CFR Part 11 has 57 controls organised across 12 domains. The largest domains are Electronic Signature (16 controls), Closed System (6 controls), FDA 21 CFR Part 11: Administrative Safeguards (6 controls). Each control defines specific requirements that organisations must implement to achieve compliance.
What frameworks does FDA 21 CFR Part 11 map to?
FDA 21 CFR Part 11 maps to 567 other compliance frameworks. The top mapping partners are NIS2 Directive Implementing Acts (19% coverage), ISO 13485 (19% coverage), UK Telecommunications (Security) Act 2021 (19% coverage). Use our comparison tool to explore control-level mappings between frameworks.
How do I get started with FDA 21 CFR Part 11 compliance?
Start your FDA 21 CFR Part 11 compliance journey by running a self-assessment on our platform to identify your current compliance posture. Our AI advisory can answer specific questions about FDA 21 CFR Part 11 requirements, and cross-framework mapping helps you leverage existing controls from other frameworks you may already comply with. Create a free account to access all 57 controls and track your progress.
Start Your Compliance Journey
Create a free account to run self-assessments, get AI advisory, and track your compliance progress across 700 frameworks.
Get Started Free →Free forever — no credit card required